---
title: "28 stocks will face lifting of restrictions next week"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231914678.md"
description: "Next week, 28 stocks will be unlocked, with a total market value exceeding 12.6 billion yuan based on the latest closing prices. KTC will have 150 million shares listed for circulation next week, mainly consisting of the original shareholders' restricted shares from the initial public offering, with an unlocked market value of 3.562 billion yuan. In terms of the unlocking ratio, LIHANG TECHNOLOGY's unlocking ratio exceeds 50%, reaching 65.73%; stocks such as Hujiang Materials, Fangsheng Pharmaceutical, and Zhiyuan Interconnection have relatively small unlocking ratios, all below 1%"
datetime: "2025-03-14T23:49:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231914678.md)
  - [en](https://longbridge.com/en/news/231914678.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231914678.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/231914678.md) | [繁體中文](https://longbridge.com/zh-HK/news/231914678.md)


# 28 stocks will face lifting of restrictions next week

Next week, 28 stocks will be released from restrictions. Based on the latest closing prices, the total market value of the released stocks exceeds 12.6 billion yuan. KTC will have 150 million shares listed for circulation next week, mainly consisting of the original shareholders' restricted shares from the initial public offering, with a market value of 3.562 billion yuan. In terms of the release ratio, LIHANG TECHNOLOGY's release ratio exceeds 50%, reaching 65.73%; stocks such as Hujiang Materials, Fangsheng Pharmaceutical, and Zhiyuan Hulian have relatively small release ratios, all below 1%

### Related Stocks

- [LIHANG TECHNOLOGY (603261.CN)](https://longbridge.com/en/quote/603261.CN.md)
- [KTC (001308.CN)](https://longbridge.com/en/quote/001308.CN.md)
- [Fangsheng Pharmaceutical (603998.CN)](https://longbridge.com/en/quote/603998.CN.md)
- [Seeyon (688369.CN)](https://longbridge.com/en/quote/688369.CN.md)